Impact Factor
3.20
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.00
833 total citations
h5-index
30
h5 depth signal
Cited share
61.7%
267 of 433
Total citations
833
Citation footprint
Metric signal
1.83
External metric anchor
Self-citation
9.0%
75 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,081
Australia
140
Spain
136
Italy
132
Canada
109
Citing Fields of Research
Transplantation
957
Viral Identification & Phylogenetics
447
Kidney Diseases
381
Fungal Pathogenesis
376
Hematology
292
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,728
Articles tracked across the journal lifetime
Indexed publication set
433
267 cited publications
Last 12 months
221
18.4 publications/month
Open access share
33.5%
74 OA publications in the last year
Leading citing country
United States
1,081 citing publications
Leading citing field
Transplantation
957 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Mar. 1999-
v1n1, Mar. 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
Transplantation
Fungal Pathogenesis
Antibiotic & Antibacterial Agents
Viral Identification & Phylogenetics
Kidney Diseases
Hematology
Issuing & Sponsoring Bodies
Contributor
Transplantation Society
Broad Categories
Transplantation
Viral Identification & Phylogenetics
Antibiotic & Antibacterial Agents
Fungal Pathogenesis
Virology
MeSH Descriptors
Communicable Diseases
Infection Control
Infections
Transplantation
Transplants
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1111/tid.70338
Open DOI
Early Invasive Fungal Infections in Liver Transplant Recipients Receiving Risk‐Stratified Echinocandin Prophylaxis: A Descriptive Single‐Center Cohort Study
Background: Invasive fungal infection (IFI) remains a cause of morbidity and mortality after liver transplantation; guidelines recommend targeted antifungal prophylaxis in recipients with specific risk factors. Methods: We retrospectivel...
03
DOI 10.1111/tid.70337
Open DOI
A Novel Indicator of Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation: Current CMV Reactivation
Background: Cytomegalovirus reactivation (CMVR) after allogeneic hematopoietic cell transplantation (allo‐HCT) is a reversible event, and conventional indicators such as the simple cumulative incidence cannot reflect transitional CMVR st...
04
05
DOI 10.1111/tid.70321
Open DOI
Prophylaxis Durations and Risks of Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: An International, Multicenter Cohort Study
Background: The optimal duration of cytomegalovirus (CMV) prophylaxis in solid organ transplant recipients (SOTr) remains undetermined. We evaluated real‐life preventive strategies on the incidence of CMV disease in an international SOTr...
06
DOI 10.1111/tid.70332
Open DOI
Cytomegalovirus Infections Following Pediatric Hematopoietic Stem Cell Transplantation: An 18‐Year Single‐Center Experience
Aim: The aim of this study was to evaluate the risk factors for CMV reactivation and the effects of CMV on HSCT outcomes in patients managed using a standard prophylaxis and preemptive treatment approach in settings where letermovir prop...
07
DOI 10.1111/tid.70333
Open DOI
Pneumocystis jirovecii Pneumonia Outbreaks in Solid Organ Transplant Recipients: A Systematic Review of Epidemiology, Transmission Dynamics, and Outbreak Investigations
Background: Although Pneumocystis jirovecii pneumonia (PJP) outbreaks continue to occur in solid organ transplantation (SOT) recipients, no systematic review has synthesized the available evidence to provide an aggregated understanding o...
08
DOI 10.1111/tid.70324
Open DOI
Letermovir in Refractory and Resistant CMV After Lung Transplantation: Therapeutic Potential and Emergence of Resistance
Background: Cytomegalovirus (CMV) infection remains a major challenge in lung transplant (LTx) recipients, particularly in antiviral‐resistant or refractory (R/R) cases. Letermovir, effective for prophylaxis, has been used off‐label as s...
09
DOI 10.1111/tid.70330
Open DOI
Post‐Pyloric Enteral Immunoglobulin for Treatment of Chronic Norovirus Diarrhea in Solid Organ Transplant Recipients: A Single Center Retrospective Study
Background: Norovirus can cause devastating, chronic diarrhea in immunocompromised individuals. There is no approved therapy for this infection. Case series have described oral immunoglobulin (Ig) as a treatment option, but destruction b...
10
DOI 10.1111/tid.70334
Open DOI
CMV in Solid Organ Transplantation: A Persistent and Costly Burden
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with 2013.
Also issued online.